PrognomiQ is developing test products that enable early disease detection and treatment, focusing on multi-omics data for insights into cancer and other complex diseases.
investor of
competitor of
Metrics
marketPRIVATE
msh_idCOM:PROGNOMIQ
localeus
websitehttps://prognomiq.com
source_ref072022fc-13ce-4e51-87ae-cfd74fbf073b
products_or_servicesTest products for early disease detection and treatment utilizing multi-omics data.
United States